Lotus Pharmaceutical Co., Ltd.

TWSE:1795.TW

271 (TWD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) TWD.

202320222021202020192018201720162015201420132012201120102009
Operating Activities:
Net Income 4,105.6263,940.2121,870.0191,304.235876.42163.704210.81419.26304.867-586.80722.187-193.234-38.40315.0513.117
Depreciation & Amortization 1,210.639936.866759.381709.624586.693391.539362.867306.782296.66163.16670.5962.38343.84327.25524.935
Deferred Income Tax -5,479.5990-69.118-166.687000000028.566000
Stock Based Compensation 106.49339.4157.65731.21800000002.518000
Change In Working Capital -3,437.93-909.702-2,833.183-299.003-1,333.92433.24572.065177.296332.814-687.219-196.5130.092-32.4894.67556.268
Accounts Receivables -1,669.081-1,416.191-637.811-361.018-1,142.58279.4770.588221.852497.695-82.51-191.02829.004000
Inventory -623.175-313.294-1,125.413-1,097.508-286.196-331.86138.437-208.73232.546-117.077-70.439-6.079-37.5356.377-9.533
Accounts Payables -659.572648.39-980.983996.453132.845315.368-62.19785.663-41.61000000
Other Working Capital -486.102171.393-88.976163.07-37.993365.10633.628386.028300.268-570.142-126.07136.1715.046-1.70265.801
Other Non Cash Items 5,119.001-287.368334.906369.295173.62208.49-53.453729.663143.23278.4527.89615.222-49.24512.2135.179
Operating Cash Flow 1,624.233,719.418119.6621,948.682302.809796.978592.2931,233.0011,077.573-1,032.408-95.837-54.453-76.29459.19489.499
Investing Activities:
Investments In Property Plant And Equipment -3,275.024-3,069.391-1,615.75-1,997.54-1,102.714-399.067-914.839-660.483-520.712-222.888-33.474-80.91-187.897-147.575-25.169
Acquisitions Net 1.2549.3750.118.449-679.3231.061-916.603-558.476-225.839-4,551.08700000
Purchases Of Investments -43.489-1,605.62170.848407.019-616.49800-25.353-23.026-16.27500000
Sales Maturities Of Investments 43.489-9.37570.84812.13679.323025.35355.33389.9331.03700000
Other Investing Activites 14.45718.864-102.899445.109-669.044-99.27-19.119611.861488.6265.69320.028-25.828-1.1924.615-4.647
Investing Cash Flow -3,259.313-4,656.148-1,576.843-1,124.833-2,388.256-498.337-908.605-577.118-191.024-4,723.52-13.446-106.738-189.089-142.96-29.816
Financing Activities:
Debt Repayment -2,416.02-5,274.954-6,441.613-3,589.579-420-4,359.583-4,114.943-88.153-154.26-996.86-505.271-4.3290-16.25-31.667
Common Stock Issued 0.59801,413.650616.60900001,834.839675237.5095.44848
Common Stock Repurchased -108.3170-57.35400000-22.88800-3.57-0.826368.5520
Dividends Paid -906.227-506.058-92.00500000000-145-13.373-4.075-6.899
Other Financing Activities 4,832.6387,042.7436,840.5133,044.2722,028.4423,401.4574,133.108-62.963-203.9774,690.17475773.353-0.0880.088-25
Financing Cash Flow 1,402.6721,261.7311,663.191-545.3072,225.051-958.12618.165-151.116-381.1255,528.153926.729157.954-14.287443.763-15.566
Other Information:
Effect Of Forex Changes On Cash 19.90852.887-89.519-66.403-38.117-91.45556.906-67.535-22.759-5.521.5562.1291.978-0.907-0.26
Net Change In Cash -261.174377.888116.491212.139101.487-750.94-241.241437.232482.665-233.295819.002-1.108-277.692359.0943.857
Cash At End Of Period 1,770.881,983.3831,605.4951,489.0041,124.7191,023.2321,774.1722,015.4131,578.1811,095.5161,009.886190.884191.992469.684110.594